NTP-TERAZOSIN DIN 02346753
Status: Cancelled Pre Market
Holder: TEVA CANADA LIMITED
Molecule: TERAZOSIN (TERAZOSIN HYDROCHLORIDE)
Health Canada record
| Active ingredient(s) | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G04CA03 TERAZOSIN |
| Original market date | |
| Current status date | 06-Aug-2015 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TERAZOSIN (TERAZOSIN HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02234502 | APO-TERAZOSIN | APOTEX INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Marketed |
| 02234505 | APO-TERAZOSIN | APOTEX INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Marketed |
| 02234504 | APO-TERAZOSIN | APOTEX INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Marketed |
| 02234503 | APO-TERAZOSIN | APOTEX INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Marketed |
| 02558645 | JAMP TERAZOSIN | JAMP PHARMA CORPORATION | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Approved |
| 02558688 | JAMP TERAZOSIN | JAMP PHARMA CORPORATION | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Approved |
| 02558661 | JAMP TERAZOSIN | JAMP PHARMA CORPORATION | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Approved |
| 02558653 | JAMP TERAZOSIN | JAMP PHARMA CORPORATION | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Approved |
| 02243518 | PMS-TERAZOSIN | PHARMASCIENCE INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Marketed |
| 02243521 | PMS-TERAZOSIN | PHARMASCIENCE INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Marketed |
| 02243520 | PMS-TERAZOSIN | PHARMASCIENCE INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Marketed |
| 02243519 | PMS-TERAZOSIN | PHARMASCIENCE INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Marketed |
| 02233047 | TERAZOSIN | APOTEX INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Approved |
| 02233050 | TERAZOSIN | APOTEX INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Approved |
| 02233049 | TERAZOSIN | APOTEX INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Approved |
| 02233048 | TERAZOSIN | APOTEX INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Approved |
| 02243748 | DOM-TERAZOSIN | DOMINION PHARMACAL | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Cancelled Post Market |
| 02243746 | DOM-TERAZOSIN | DOMINION PHARMACAL | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 02243747 | DOM-TERAZOSIN | DOMINION PHARMACAL | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Cancelled Post Market |
| 02243749 | DOM-TERAZOSIN | DOMINION PHARMACAL | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Cancelled Post Market |
| 02187876 | HYTRIN-7 TABS 1MG-7 TABS 2MG-14 TABS 5MG | ABBOTT LABORATORIES, LIMITED | Kit; Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG; TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG; TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Cancelled Post Market |
| 02346737 | NTP-TERAZOSIN | TEVA CANADA LIMITED | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Cancelled Pre Market |
| 02346761 | NTP-TERAZOSIN | TEVA CANADA LIMITED | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Cancelled Pre Market |
| 02346745 | NTP-TERAZOSIN | TEVA CANADA LIMITED | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Cancelled Pre Market |
| 02246545 | PHL-TERAZOSIN | PHARMEL INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Cancelled Post Market |
| 02246547 | PHL-TERAZOSIN | PHARMEL INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Cancelled Post Market |
| 02246546 | PHL-TERAZOSIN | PHARMEL INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Cancelled Post Market |
| 02246544 | PHL-TERAZOSIN | PHARMEL INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 02240729 | RIVA-TERAZOSIN 1 MG TABLETS | LABORATOIRE RIVA INC. | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 02240732 | RIVA-TERAZOSIN 10 MG TABLETS | LABORATOIRE RIVA INC. | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Cancelled Post Market |
| 02240730 | RIVA-TERAZOSIN 2 MG TABLETS | LABORATOIRE RIVA INC. | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Cancelled Post Market |
| 02240731 | RIVA-TERAZOSIN 5 MG TABLETS | LABORATOIRE RIVA INC. | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Cancelled Post Market |
| 02350483 | TERAZOSIN | SANIS HEALTH INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Cancelled Post Market |
| 02350475 | TERAZOSIN | SANIS HEALTH INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 02350491 | TERAZOSIN | SANIS HEALTH INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Cancelled Post Market |
| 02350505 | TERAZOSIN | SANIS HEALTH INC | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Cancelled Post Market |
| 02237476 | TERAZOSIN-1 | PRO DOC LIMITEE | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Cancelled Post Market |
| 02237479 | TERAZOSIN-10 | PRO DOC LIMITEE | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Cancelled Post Market |
| 02237477 | TERAZOSIN-2 | PRO DOC LIMITEE | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Cancelled Post Market |
| 02237478 | TERAZOSIN-5 | PRO DOC LIMITEE | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Cancelled Post Market |
| 02230808 | TEVA-TERAZOSIN | TEVA CANADA LIMITED | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 10 MG | Dormant |
| 02230806 | TEVA-TERAZOSIN | TEVA CANADA LIMITED | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 2 MG | Dormant |
| 02230807 | TEVA-TERAZOSIN | TEVA CANADA LIMITED | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 5 MG | Dormant |
| 02230805 | TEVA-TERAZOSIN | TEVA CANADA LIMITED | Tablet | TERAZOSIN (TERAZOSIN HYDROCHLORIDE) 1 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14694 | 2013-07-04 | Abbreviated New Drug Submission (ANDS) | ADMINISTRATIVE MERGER/BUYOUT |
| 11173 | 2010-03-25 | Abbreviated New Drug Submission (ANDS) | New manufacturer and product name |